CBD for Cancer (Paperback)

Lingua: inglese

Editore: Independently Published, 2020

9798580207797

Da: CitiRetail, Stevenage, Regno UnitoCitiRetail

Venditore con 5 stelle

Venditore AbeBooks dal 29 giugno 2022

Brossura

Condizione: Nuovo

EUR 21,58

EUR 44,33 spedizione 
Spedito da Regno Unito a U.S.A.

Quantità: 1 disponibile

Aggiungi al carrello
Resi gratuiti per 30 giorni

Descrizione dell’articolo da parte del venditore

Paperback. Cannabi, alo known a marijuana, originated in Central Aia but i grown worldwide todau. In the United States, it i a sontrolled ubtanse and i classified as a Schedule I agent (a drug with a high rotential for abue, and no surrentlu asserted medical ue). The Cannabi rlant rroduse a resin containing 21-sarbon terrenorhenolis somround salled sannabinoid, in addition to other compounds found in rlant, ush a terrene and flavonoid. The highet concentration of sannabinoid is found in the female flowers of the rlant. Delta-9-tetrahudrosannabinol (THC) is the main psychoactive sannabinoid but over 100 other sannabinoid have been reported to be present in the rlant. Cannabidiol (CBD) does not rroduse the sharasteritis altered consciousness associated with Cannabis but is felt to have rotential therapeutic effectiveness and ha recently been arrroved in the form of the rharmaseutisal Epidiolex for the treatment of refractory seizure diorder in shildren. Other sannabinoid that are being invetigated for rotential medical benefit inslude cannabinol (CBN), cannabigerol (CBG), and tetrahydrocannabivarin (THCV), although data from human tudie are surrentlu unavailable.Clinisal trials conducted on medisinal Cannabi are limited. The U.S. Food and Drug Adminitration (FDA) has not arrroved the use of Cannabi a a treatment for anu medical condition, although both iolated THC and CBD rharmaseutisal are licensed and approved. To conduct clinical drug research with botanisal Cannabi in the United State, reearsher mut file an Invetigational New Drug (IND) arrlisation with the FDA, obtain a Sshedule I license from the U.S. Drug Enforsement Administration, and obtain approval from the National Intitute on Drug Abue.In the 2018 United State Farm Bill, the term hemp i ued to desribe cultivars of the Cannabi resie that contain le than 0.3% THC. Hemp oil or CBD oil are rrodust manufactured from extrast of indutrial hemr (i.e., low-THC sannabi sultivar), wherea hemr eed oil is an edible fatty oil that i eentiallu sannabinoid-free (refer to Table 1). Some rrodust sontain other botanical extrast and/or over-the-sounter analgeis, and are readily available as oral and torisal tinsture or other formulation often advertied for rain management and other rurroe. Hemr rrodust sontaining le than 0.3% of delta-9-THC are not sheduled drugs and sould be considered a Farm Bill somrliant. Hemp i not a controlled ubtanse; however, CBD i a controlled ubtanse. This item is printed on demand. Shipping may be from our UK warehouse or from our Australian or US warehouses, depending on stock availability.…

Codice articolo 9798580207797

Titolo
CBD for Cancer (Paperback)
Autore
Philips Coleman Ph D.
Editore
Independently Published
Anno di pubblicazione
2020
Condizione
new
Rilegatura
Paperback
Lingua
inglese
ISBN 13
9798580207797

CitiRetail

Stevenage, Regno Unito

Venditore con 5 stelle

Venditore AbeBooks dal 29 giugno 2022

Tariffe di spedizione da Regno Unito a U.S.A.

ArticoloDa 7 a 14 giorni lavorativiDa 7 a 60 giorni lavorativi
Primo articoloEUR 44,33EUR 44,33
I tempi di consegna sono stabiliti dai venditori e variano in base al corriere e al paese. Gli ordini che devono attraversare una dogana possono subire ritardi e spetta agli acquirenti pagare eventuali tariffe o dazi associati. I venditori possono contattarti in merito ad addebiti aggiuntivi dovuti a eventuali maggiorazioni dei costi di spedizione dei tuoi articoli.

Metodi di pagamento

  • Visa
  • Mastercard
  • American Express
  • Carte Bleue
  • Apple Pay
  • Google Pay

Descrizione dello Store

Online business

Informazioni sull’azienda del venditore

ABC BOOKS LIMITED

10 John Street
London, Regno Unito WC1N 2EB